Anti-mitotic Drugs Current Events | Anti-mitotic Drugs News | 7
|
| Page
7 of
58 |
1150 Results |
|
|
|
Sort By:
Page Views | Date |
Human testis harbors HIV-1 in resident immune cells
Researchers have demonstrated HIV replication within resident immune cells of the testis, providing an explanation for the persistence of virus in semen even after effective highly active antiretroviral therapy. view more (2006-11-27)
Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models. view more (2008-11-24)
Angiogenesis inhibitor improves brain tumor survival by reducing edema
The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct anti-tumor effect. view more (2009-03-30)
New analytical techniques developed to quantify composition of fake anti-malarials
Researchers led by the Georgia Institute of Technology are developing novel analytical chemistry techniques to detect and quantify the contents of counterfeit anti-malarial drugs and other fake pharmaceuticals. view more (2006-06-14)
Safety claims of new arthritis drugs may be misleading
Popular arthritis drugs, known as selective COX 2 inhibitors, may not be superior to traditional non-steroidal anti-inflammatory drugs, conclude researchers in this week’s BMJ. view more (2002-05-28)
HIV drug resistance risk in mothers reduced by combination of common drugs
New research from the University of Alabama at Birmingham (UAB) shows that adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options. view more (2007-11-12)
New understanding of COX-1 and COX-2 enzymes could lead to revised classification of pain meds, Queen's study shows
COX-1 and COX-2 enzymes may be blocked by pain medications such as Advil and Vioxx in a more complex manner than was previously understood, a Queen's University study has found. view more (2006-05-30)
Self-assembling nano-fiber gel delivers high concentrations of clinically approved drugs
Two teams of scientists from Harvard-MIT Division of Health Science and Technology (HST) at Brigham and Women's Hospital have developed a new self-assembling hydrogel drug delivery system that is biocompatible, efficient at drug release, and easy to tailor. view more (2008-10-22)
The Tiny Difference that Created the Universe
Roughly 15 billion years ago, during the Big Bang, equal amounts of matter and anti-matter should have been created, with an anti-particle for every particle created. Yet when matter and anti-matter meet, they both disappear in a flash of light, so why didn't they annihilate each other completely? For some reason, during the first moments of the... view more... (2002-05-07)
Rising rates of bleeding from ulcers in last decade despite changes in treatment
Hospital admissions for bleeding ulcers rose throughout the 1990s despite changes in drug treatment, reveals a study in Gut. view more (2002-03-11)
New role for sugars: Research shows connections between sugar modifications in cells and cancer
In a ground-breaking study published in the top journal, Cell, Dr. James Dennis, senior investigator at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, has discovered a new role for sugars on proteins. view more (2007-04-06)
RESEARCH AIMS TO HELP THOSE WITH CHRONIC LUNG DISEASE
The Novartis Horsham Research Centre has awarded a grant of £143,846 to William MacNee, Professor of Respiratory and Environmental Medicine, to investigate COPD with a view to helping develop anti-inflammatory therapy for the condition. view more (1999-06-21)
Biotransformed blueberry juice fights fat and diabetes
Juice extracted from North American lowbush blueberries, biotransformed with bacteria from the skin of the fruit, holds great promise as an anti-obesity and anti-diabetic agent. view more (2009-09-01)
Potential pharmaceutical drugs in the field of cancer
Raquel Villar Becares, in her PhD thesis at the Public University of Navarre, has developed new derivatives of benzo[b]tiophene 1,1-dioxide that enable their application in the pharmaceutical field. view more (2005-12-23)
Knocking nanoparticles off the socks
Scientists in Switzerland are reporting results of one of the first studies on the release of silver nanoparticles from laundering those anti-odor, anti-bacterial socks now on the market. view more (2009-10-29)
New tool to speed cancer therapy approval available
Although cancer remains a leading cause of death in America, it can take up to 12 years to bring a new anti-cancer agent before the FDA and the success rate for approval is only five to 10 percent. That means many research hours and dollars are wasted chasing avenues that will not bring fruit. view more (2008-09-15)
Newly-identified exercise gene could help with depression
Boosting an exercise-related gene in the brain works as a powerful anti-depressant in mice-a finding that could lead to a new anti-depressant drug target, according to a Yale School of Medicine report in Nature Medicine. view more (2007-12-03)
Dormant TB beats our best drugs
New knowledge about the way tuberculosis-causing bacteria can survive in a dormant state for years in our bodies could pave the way for treatments that will finally wipe out this dread disease, experts heard today (Monday 10 September 2001) at the bi-annual meeting of the Society of General Microbiology at the University of East Anglia. US... view more... (2001-08-31)
Canadian research breakthrough holds promise for development of effective cancer therapies
Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer... view more... (2009-09-03)
New role for Natural Killers!
Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer. view more (2008-08-28)
|
|
| Page
7 of
58 |
1150 Results |
|
|
|
Sort By:
Page Views | Date |
|
